OSL oncosil medical ltd

News: OSL Oncosil Medical Says FDA Grants Breakthrough Device Designation For Oncosil Device

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    March 18 (Reuters) - Oncosil Medical Ltd (OSL) :

    • FDA GRANTS BREAKTHROUGH DEVICE DESIGNATION FOR ONCOSIL DEVICE FOR TREATMENT OF UNRESECTABLE PANCREATIC CANCER
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
97.0¢
Change
-0.035(3.48%)
Mkt cap ! $14.22M
Open High Low Value Volume
$1.00 $1.01 97.0¢ $61.57K 61.82K

Buyers (Bids)

No. Vol. Price($)
4 11059 97.0¢
 

Sellers (Offers)

Price($) Vol. No.
$1.00 3387 2
View Market Depth
Last trade - 14.26pm 23/06/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.